Middle East and Africa Virology Market to Grow at a CAGR of 2.8% to reach US$ 221.46 million from 2021 to 2028

Middle East and Africa Virology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes)

  • Report Code : TIPRE00025741
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 187
Buy Now

The virology market in MEA is expected to grow from US$ 182.40 million in 2021 to US$ 221.46 million by 2028; it is estimated to grow at a CAGR of 2.8% from 2021 to 2028.

The UAE, Saudi Arabia, and South Africa are economies in MEA. Plant-derived vaccines and biopharmaceuticals do not need costly fermentation and purification systems and other costs associated with cold storage, transportation, and sterile distribution when administered orally. In general, chloroplasts deliver high levels of vaccine antigen expression against bacterial, viral, and protozoan pathogens and biopharmaceuticals and the containment of transgenes by maternal inheritance. In the past eight years, the chloroplast system for therapeutic protein expression has been established. Also, the recent development of an efficient lettuce chloroplast system for oral delivery is a significant advancement. Moreover, at-home health diagnostics is gaining popularity among patients. As a response to the virology market, players are developing at-home test kits that help in easy and quick diagnosis and help in taking immediate medical treatment. For instance, in November 2020, the USFDA issued an emergency use authorization (EUA) Lucira COVID-19 all-in-one test kit.

Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries like Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in a deep economic recession due to the US sanctions. Additionally, tightened financial condition is also decreasing the economic activities in the region. COVID-19 is the second coronavirus outbreak that has affected the Middle East, following the MERS-CoV reported in Saudi Arabia in 2012. Many countries are facing a shortage of testing kits in the region. Considering this, many government organizations are coming forward to help countries with a lack of resources. For instance, in September, The United Nations Children’s Fund (UNICEF) delivered around 115,800 Covid-19 test kits to help mitigate the Covid-19 pandemic in Nigeria. Also, the countries in the region are collaborating with international players to increase the testing capacity. In addition, the substantial direct health, and economic impacts of the Ebola epidemic in Guinea, Liberia, and Sierra Leone, diverted basic health care and government services to the outbreak, resulting in serious under-provision of health and social care. Economic growth also slowed significantly due to reduced financial investments and productivity levels during and after the outbreak. As per the Global Fund Organization, across 24 countries in Africa, only 11% of health facilities could conduct COVID-19 antigen rapid diagnostic tests, and only 8% could conduct PCR tests. Before the COVID-19, Lassa Fever was the priority, with the annual incidence of around 300,000-500,000 cases of Lassa Fever, with 5,000 related deaths in West Africa. However, COVID-19 has diverted all the rescores in handling the pandemic has impeded the growth of the other virus infections.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive virology market. The MEA virology market is expected to grow at a good CAGR during the forecast period.

 MEA virology market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

MEA Virology Market Segmentation

MEA Virology Market – By Type

  • Diagnostic Test
    • DNA Virus Testing
    • RNA Virus Testing
    • Others
  • Viral Infection Controlling Techniques
    • Active Prophylaxis
    • Passive Prophylaxis
  • Antiviral Therapeutics
    • Virucidal Agents
    • Antiviral Agents
    • Immunomodulators
  • Interferons

MEA Virology Market – By Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Others

MEA Virology Market – By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Research and Academic Institutes

MEA Virology Market- By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

MEA Virology Market-Companies Mentioned

  • Abbott
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline Plc
  • Illumina, Inc.
  • Johnson and Johnson Services, Inc.
  • QIAGEN
  • Siemens AG
  • Thermo Fisher Scientific Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Virology Market – By Type

1.3.2 MEA Virology Market – By Application

1.3.3 MEA Virology Market – By End User

1.3.4 MEA Virology Market– By Country

2. MEA Virology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Virology Market– Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Virology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Viral Infectious Diseases

5.1.2 Increasing Product Launches

5.2 Market Restraints

5.2.1 Availability of Alternative Products and High Price of Production of Products

5.3 Market Opportunities

5.3.1 Major Growth Potential in Emerging Economies

5.4 Future Trends

5.4.1 Continuous Requirement for Cost-Effective Products

5.5 Impact Analysis

6. Virology Market– MEA Analysis

6.1 MEA Virology Market Revenue Forecast and Analysis

7. MEA Virology Market Analysis – By Type

7.1 Overview

7.2 MEA Virology Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Test

7.3.1 Overview

7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1 Overview

7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1 Overview

7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Others

7.3.2.3.1 Overview

7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Viral Infection Controlling Techniques

7.4.1 Overview

7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Active Prophylaxis

7.4.2.1.1 Overview

7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Passive Prophylaxis

7.4.2.2.1 Overview

7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Antiviral Therapeutics

7.5.1 Overview

7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Virucidal Agents

7.5.2.1.1 Overview

7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Antiviral Agents

7.5.2.2.1 Overview

7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Immunomodulators

7.5.2.3.1 Overview

7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Interferons

7.6.1 Overview

7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8. MEA Virology Market Analysis – By Application

8.1 Overview

8.2 MEA Virology Market, by Application 2021 & 2028 (%)

8.3 Skin and Soft Tissue Infections

8.3.1 Overview

8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Respiratory Tract Infections

8.4.1 Overview

8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 GI Tract Infections

8.5.1 Overview

8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Sexually Transmitted Diseases

8.6.1 Overview

8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Virology Market Analysis – By End User

9.1 Overview

9.2 MEA Virology Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pharmaceutical and Biotechnological Companies

9.5.1 Overview

9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Research and Academic Institutes

9.6.1 Overview

9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Virology Market – Country Analysis

10.1.1 Overview

10.1.2 Middle East & Africa: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1 Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Saudi Arabia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.2.2 Saudi Arabia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.2.3 Saudi Arabia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.3 Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2 UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 UAE Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 UAE: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.2.2 UAE: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.2.3 UAE: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.3 UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 South Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.2.2 South Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.2.3 South Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.3 South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4 Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1 Rest of Middle East and Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.4.2.2 Rest of Middle East and Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.4.2.3 Rest of Middle East and Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.4.3 Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Impact of COVID-19 Pandemic on MEA Virology Market

11.1 Overview

12. MEA Virology Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Johnson and Johnson Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 F. HOFFMANN-LA ROCHE LTD.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QIAGEN

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline Plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 AbbVie Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gilead Sciences, Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2. Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5. Saudi Arabia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6. Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7. Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8. UAE Virology Market, By Type – Revenue and Forecast to 2028(USD Million)

Table 9. UAE Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10. UAE Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11. UAE Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12. UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13. UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 15. South Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16. South Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17. South Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18. South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Middle East and Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Middle East and Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Middle East and Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25. Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26. Organic Developments Done by Companies

Table 27. Inorganic Developments Done by Companies

Table 28. Glossary of Terms, Virology Market

LIST OF FIGURES

Figure 1. MEA Virology Market Segmentation

Figure 2. MEA Virology Segmentation, By Country

Figure 3. MEA Virology Market Overview

Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in MEA Virology Market

Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in MEA Virology Market

Figure 6. South Africa to Show Significant Growth During Forecast Period

Figure 7. MEA PEST Analysis

Figure 8. MEA Virology Market: Impact Analysis of Drivers and Restraints

Figure 9. MEA Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10. MEA Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11. MEA Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. MEA DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. MEA RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. MEA Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. MEA Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. MEA Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. MEA Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. MEA Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. MEA Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. MEA Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. MEA Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. MEA Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. MEA Virology Market, by Application 2021 & 2028 (%)

Figure 24. MEA Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. MEA Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. MEA GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. MEA Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. MEA Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. MEA Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. MEA Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31. Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Middle East and Africa: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36. Middle East & Africa: Virology Treatment Market, by Country, 2021 & 2028 (%)

Figure 37. Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. UAE: Virology Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. Impact of COVID-19 Pandemic on Virology Market in MEA Countries

  1. Abbott
  2. AbbVie Inc.
  3. F. Hoffmann-La Roche Ltd.
  4. Gilead Sciences, Inc.
  5. GlaxoSmithKline Plc
  6. Illumina, Inc.
  7. Johnson and Johnson Services, Inc.
  8. QIAGEN
  9. Siemens AG
  10. Thermo Fisher Scientific Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Middle East and Africa Virology Market